Canopy Kratom
Established vendor offering a wide variety of strains with regular third-party testing.
2
Products
2
Batches
723
Days Since Test
81/20
83/30
84/20
80/15
76/15
Canopy Kratom is a United States-based vendor that has established itself as a reputable source for kratom products since its inception. The company is GMP certified, ensuring adherence to good manufacturing practices. Although not verified on Kratom Test, Canopy Kratom offers a limited product range featuring two categories: capsules and extracts, with an average product price of $34.99. The vendor specializes in two strain types: white and blends, and their website can be found at https://canopykratom.com.
In terms of quality and value, Canopy Kratom has an average transparency score of 84/100, with specific strengths in heavy metal safety (84/20) and potency consistency (83/30). However, the completeness of their Certificates of Analysis (COA) is relatively low at 81/20, indicating a potential area for improvement. The vendor has conducted testing on two batches through ISO-certified labs, Pacific Analytical and Wonderland Labs. Despite these positive attributes, the vendor is flagged with one critical risk and five warnings, which could raise concerns for some consumers. Price-value positioning indicates that their products are considered overpriced at $5.60/100mg of mitragynine, while a fair value is noted at $2.17/100mg of mitragynine, suggesting a need for better alignment between quality and pricing.
AI-generated from lab results and public data — not a substitute for independent research.
84 / 100
Vendor Score · 2 products · 3 batches
81.0
83.0
84.0
80.0
76.0
Transparency Score Radar
Score Breakdown
Lab Accreditation Status
Batch Recency
Risk Flags (6)
Mitragynine spiked 42% from 3.4% to 4.82% — may indicate inconsistent extraction process
Mitragynine spiked 28% from 1.05% to 1.35% between batches
Cadmium at 72% of safety limit (0.036/0.05 ppm) — elevated and trending upward across batches
Lead result of 0.45 ppm approaches the 0.50 ppm threshold. While still passing, this is higher than typical readings for extract products.
7-Hydroxymitragynine at 0.12% — above 0.1% threshold but expected for extract products. Flagged for transparency.
COA document has 91% text similarity with lab report from batch GR-2023-002. May indicate templated or recycled reports.